Japanese practicing physicians' relationships with pharmaceutical representatives: A national survey

PLoS ONE

Volumn 5, Issue 8, 2010, Pages

  Saito, Sayaka ^a   Mukohara, Kei ^b   Bito, Seiji ^c  

^a TSUKUBA MEDICAL CENTER HOSPITAL   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION NAGASAKI MEDICAL CENTER   (Japan)

^c NATIONAL HOSPITAL ORGANIZATION TOKYO MEDICAL CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTINUING EDUCATION; DRUG INDUSTRY; DRUG INFORMATION; DRUG MARKETING; GENERAL SURGERY; GIFT GIVING; GYNECOLOGY; INTERNAL MEDICINE; JAPAN; MEAL; MEDICAL PRACTICE; MEDICAL SPECIALIST; NAMED GROUPS BY OCCUPATION; OBSTETRICS; OPHTHALMOLOGY; ORTHOPEDIC SURGERY; PEDIATRICS; PHARMACEUTICAL REPRESENTATIVE; PHYSICIAN ATTITUDE; PRESCRIPTION; PSYCHIATRY; SELF REPORT; SOCIAL INTERACTION; WORKPLACE; ADVERTIZING; ATTITUDE; ETHICS; HUMAN CHARACTERISTIC; INFORMATION PROCESSING; PHYSICIAN; PSYCHOLOGICAL ASPECT; STATISTICS;

ADVERTISING AS TOPIC; ATTITUDE; DATA COLLECTION; DRUG INDUSTRY; DRUG PRESCRIPTIONS; GIFT GIVING; HUMAN CHARACTERISTICS; JAPAN; PHYSICIANS;

EID: 77957857735     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0012193     Document Type: Article

References (25)

1. McKinney WP, Schiedermayer DL, Lurie N, Simpson DE, Goodman JL, et al. (1990) Attitudes of internal medicine faculty and residents toward professional interaction with pharmaceutical sales representatives. JAMA 264: 1693-1697.
2. Brotzman GL, Mark DH (1993) The effect on resident attitudes of regulatory policies regarding pharmaceutical representative activities. J Gen Intern Med 8: 130-134.
3. Reeder M, Dougherty J, White LJ (1993) Pharmaceutical representatives and emergency medicine residents: a national survey. Ann Emerg Med 22: 1593-1596.
4. Thomson AN, Craig BJ, Barham PM (1994) Attitudes of general practitioners in New Zealand to pharmaceutical representatives. Br J Gen Pract 44: 220-223.
5. Hodges B (1995) Interactions with the pharmaceutical industry: experiences and attitudes of psychiatry residents, interns and clerks. CMAJ 153: 553-559.
6. Aldir RE, Jarjoura D, Phinney M, Poordad F, Gutierrez R, et al. (1996) Practicing and resident physicians' views on pharmaceutical companies. J Contin Educ Health Prof 16: 25-32.
7. Sergeant MD, Hodgetts PG, Godwin M, Walker DM, McHenry P (1996) Interactions with the pharmaceutical industry: a survey of family medicine residents in Ontario. CMAJ 155: 1243-1248.
8. Strang D, Gagnon M, Molloy W, Bedard M, Darzins P, et al. (1996) National survey on the attitudes of Canadian physicians towards drug-detailing by pharmaceutical representatives. Ann R Coll Physicians Surg Can 29: 474-478.
9. Ferguson RP, Rhim E, Belizaire W, Egede L, Carter K, et al. (1999) Encounters with pharmaceutical sales representatives among practicing internists. Am J Med 107: 149-152.
10. Güldal D, Semin S (2000) The influences of drug companies' advertising programs on physicians. Int J Health Serv 30: 585-595.
11. Campbell EG, Gruen RL, Mountford J, Miller LG, Cleary PD, et al. (2007) A national survey of physician-industry relationships. N Engl J Med 356: 1742-1750.
12. Hayes TM, Allery LA, Harding KG, Owen PA (1990) Continuing education for general practice and the role of the pharmaceutical industry. Br J Gen Pract 40: 510-512.
13. Madhavan S, Amonkar MM, Elliott D, Burke K, Gore P (1997) The gift relationship between pharmaceutical companies and physicians: an exploratory survey of physicians. J Clin Pharm Ther 22: 207-215.
14. Steinman MA, Shlipak MG, McPhee SJ (2001) Of principles and pens: attitudes and practices of medicine housestaff toward pharmaceutical industry promotions. Am J Med 110: 551-557.
15. Sigworth SK, Nettleman MD, Cohen GM (2001) Pharmaceutical branding of resident physicians. JAMA 286: 1024-1025.
16. Halperin EC, Hutchison P, Barrier RC, Jr. (2004) A population-based study of the prevalence and influence of gifts to radiation oncologists from pharmaceutical companies and medical equipment manufacturers. Int J Radiat Oncol Biol Phys 59: 1477-1483.
17. McGettigan P, Golden J, Fryer J, Chan R, Feely J (2001) Prescribers prefer people: the sources of information used by doctors for prescribing suggest that the medium is more important than the message. Br J Clin Pharmacol 51: 184-189.
18. Brett AS, Burr W, Moloo J (2003) Are gifts from pharmaceutical companies ethically problematic? A survey of physicians. Arch Intern Med 163: 2213-2218.
19. Morgan MA, Dana J, Loewenstein G, Zinberg S, Schulkin J (2006) Interactions of doctors with the pharmaceutical industry. J Med Ethics 32: 559-563.
20. Watkins C, Moore L, Harvey I, Carthy P, Robinson E, et al. (2003) Characteristics of general practitioners who frequently see drug industry representatives: national cross sectional study. BMJ 326: 1178-1179.
21. Ministry of Health, Labor, and Welfare (2004) Survey of physicians, dentists and pharmacists. [Japanese] Available: http://www.mhlw.go.jp/toukei/saikin/hw/ishi/04/index.html Accessed 2010 July 18.
22. American Association for Public Opinion Research. Available: www.aapor.org Accessed 2010 July 18.
23. Dana J, Loewenstein G (2003) A social science perspective on gifts to physicians from industry. JAMA 290: 252-255.
24. Sierles FS, Brodkey AC, Cleary LM, McCurdy FA, Mintz M, et al. (2005) Medical students' exposure to and attitudes about drug company interactions: a national survey. JAMA 294: 1034-1042.
25. JAMA instruction for authors. Available: http://jama.ama-assn.org/misc/i4a.pdf Accessed 2010 July 18.